Autophagy and enhanced chemosensitivity in experimental pancreatic cancers induced by noninvasive radiofrequency field treatment

Cancer

Volumn 120, Issue 4, 2014, Pages 480-491

  Koshkina, Nadezhda V ^a,b   Briggs, Katrina ^a   Palalon, Flavio ^a   Curley, Steven A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Rice University   (United States)

Author keywords

autophagy; chemotherapy enhancer; gemcitabine; noninvasive radiofrequency; pancreatic cancer

Indexed keywords

AUTOPHAGY; CHEMOTHERAPY ENHANCER; GEMCITABINE; NONINVASIVE RADIOFREQUENCY; PANCREATIC CANCER;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL PROLIFERATION; DEOXYCYTIDINE; HUMANS; MICE; PANCREATIC NEOPLASMS; RADIO WAVES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84893752695     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28453     Document Type: Article

References (23)

1. McGahan JP, Browning PD, Brock JM, Tesluk H,. Hepatic ablation using radiofrequency electrocautery. Invest Radiol. 1990; 25: 267-270. (Pubitemid 20085776)
2. Matsui Y, Nakagawa A, Kamiyama Y, Yamamoto K, Kubo N, Nakase Y,. Selective thermocoagulation of unresectable pancreatic cancers by using radiofrequency capacitive heating. Pancreas. 2000; 20: 14-20. (Pubitemid 30022638)
3. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, McLoud TC,. Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung. Acad Radiol. 1996; 3: 929-935.
4. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004; 239: 818-825; discussion 825-827.
5. Adair ER, Blick DW, Allen SJ, Mylacraine KS, Ziriax JM, Scholl DM,. Thermophysiological responses of human volunteers to whole body RF exposure at 220 MHz. Bioelectromagnetics. 2005; 26: 448-461. (Pubitemid 41262730)
6. Kirson ED, Dbaly V, Tovarys F, et al. Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci U S A. 2007; 104: 10152-10157. (Pubitemid 47175278)
7. Taghi M, Gholamhosein R, Saeed RZ,. Effect of electromagnetic field on the polymerization of microtubules extracted from rat brain. Recent Pat Endocr Metab Immune Drug Discov. 2012; 6: 251-254.
8. Zimmerman JW, Pennison MJ, Brezovich I, et al. Cancer cell proliferation is inhibited by specific modulation frequencies. Br J Cancer. 2012; 106: 307-313.
9. Marchionni I, Paffi A, Pellegrino M, et al. Comparison between low-level 50 Hz and 900 MHz electromagnetic stimulation on single channel ionic currents and on firing frequency in dorsal root ganglion isolated neurons. Biochim Biophys Acta. 2006; 1758: 597-605. (Pubitemid 44202288)
10. Renouf D, Moore M,. Evolution of systemic therapy for advanced pancreatic cancer. Expert Rev Anticancer Ther. 2010; 10: 529-540.
11. Philip PA, Benedetti J, Corless CL, et al. Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205. J Clin Oncol. 2010; 28: 3605-3610.
12. Li M, Zhai Q, Bharadwaj U, et al. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer. 2006; 106: 2284-2294. (Pubitemid 43673252)
13. Glazer ES, Zhu C, Massey KL, et al. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles. Clin Cancer Res. 2010; 16: 5712-5721.
14. Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000; 19: 5720-5728.
15. Arumugam T, Ramachandran V, Logsdon CD,. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst. 2006; 98: 1806-1818. (Pubitemid 46017932)
16. Tang K, Zhang Z, Bai Z, Ma X, Guo W, Wang Y,. Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression. Oncol Rep. 2011; 25: 963-970.
17. Mizushima N, Yoshimori T,. How to interpret LC3 immunoblotting. Autophagy. 2007; 3: 542-545. (Pubitemid 350060049)
18. Klionsky DJ, Abdalla FC, Abeliovich H, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012; 8: 445-544.
19. Yang S, Wang X, Contino G, et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev. 2011; 25: 717-729
20. Yu L, Lenardo MJ, Baehrecke EH,. Autophagy and caspases: a new cell death program. Cell Cycle. 2004; 3: 1124-1126. (Pubitemid 40268628)
21. Laane E, Tamm KP, Buentke E, et al. Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ. 2009; 16: 1018-1029.
22. Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A,. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ. 2007; 14: 500-510.
23. Cuervo AM,. Autophagy: in sickness and in health. Trends Cell Biol. 2004; 14: 70-77. (Pubitemid 38186640)